Catherine Curdy

615 total citations
16 papers, 477 citations indexed

About

Catherine Curdy is a scholar working on Pharmaceutical Science, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Catherine Curdy has authored 16 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 9 papers in Biomaterials and 4 papers in Biomedical Engineering. Recurrent topics in Catherine Curdy's work include Advancements in Transdermal Drug Delivery (6 papers), biodegradable polymer synthesis and properties (5 papers) and Advanced Drug Delivery Systems (5 papers). Catherine Curdy is often cited by papers focused on Advancements in Transdermal Drug Delivery (6 papers), biodegradable polymer synthesis and properties (5 papers) and Advanced Drug Delivery Systems (5 papers). Catherine Curdy collaborates with scholars based in Switzerland, Germany and France. Catherine Curdy's co-authors include Richard H. Guy, Yogeshvar N. Kalia, Nicolas Anton, Thierry Vandamme, Aarti Naik, Thomas Kissel, Holger Petersen, Moritz Beck‐Broichsitter, Ingo Alberti and Bernd Riebesehl and has published in prestigious journals such as Journal of Controlled Release, Magnetic Resonance in Medicine and International Journal of Pharmaceutics.

In The Last Decade

Catherine Curdy

16 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Curdy Switzerland 12 230 139 97 76 71 16 477
Nor Hayati Abu Samah Malaysia 9 187 0.8× 138 1.0× 82 0.8× 57 0.8× 89 1.3× 11 437
Sergey O. Solomevich Belarus 12 173 0.8× 210 1.5× 145 1.5× 61 0.8× 53 0.7× 34 515
Andréa Arruda Martins Shimojo Brazil 13 111 0.5× 147 1.1× 99 1.0× 62 0.8× 34 0.5× 16 504
Peeyush Sharma India 10 159 0.7× 162 1.2× 209 2.2× 133 1.8× 31 0.4× 31 558
Miriam López-Cervantes Mexico 8 308 1.3× 100 0.7× 91 0.9× 70 0.9× 113 1.6× 9 603
Jingou Ji China 13 200 0.9× 301 2.2× 115 1.2× 71 0.9× 25 0.4× 21 645
Madeleine Witting Germany 8 209 0.9× 136 1.0× 101 1.0× 50 0.7× 141 2.0× 9 557
Birgitte M. Malle Denmark 9 80 0.3× 115 0.8× 66 0.7× 76 1.0× 92 1.3× 12 482
Mina Kwon South Korea 9 283 1.2× 104 0.7× 164 1.7× 31 0.4× 111 1.6× 16 589
Salwa Salah Egypt 15 444 1.9× 157 1.1× 120 1.2× 41 0.5× 52 0.7× 24 787

Countries citing papers authored by Catherine Curdy

Since Specialization
Citations

This map shows the geographic impact of Catherine Curdy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Curdy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Curdy more than expected).

Fields of papers citing papers by Catherine Curdy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Curdy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Curdy. The network helps show where Catherine Curdy may publish in the future.

Co-authorship network of co-authors of Catherine Curdy

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Curdy. A scholar is included among the top collaborators of Catherine Curdy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Curdy. Catherine Curdy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Curdy, Catherine, et al.. (2016). Tracking immune-related cell responses to drug delivery microparticles in 3D dense collagen matrix. European Journal of Pharmaceutics and Biopharmaceutics. 107. 180–190. 5 indexed citations
2.
Cannet, Catherine, et al.. (2015). Long‐term distribution of biodegradable microparticles in rat muscle quantified noninvasively by MRI. Magnetic Resonance in Medicine. 75(4). 1736–1742. 5 indexed citations
3.
Chu, Dafeng, Moritz Beck‐Broichsitter, Catherine Curdy, Bernd Riebesehl, & Thomas Kissel. (2014). Feasibility of macrophage mediated on-demand drug release from surface eroding poly(ethylene carbonate). International Journal of Pharmaceutics. 465(1-2). 1–4. 12 indexed citations
4.
Anton, Nicolas, et al.. (2014). Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 88(2). 361–373. 44 indexed citations
5.
Anton, Nicolas, et al.. (2013). Thermosensitive chitosan/glycerophosphate-based hydrogel and its derivatives in pharmaceutical and biomedical applications. Expert Opinion on Drug Delivery. 11(2). 249–267. 129 indexed citations
6.
Chu, Dafeng, Catherine Curdy, Bernd Riebesehl, et al.. (2013). Enzyme-responsive surface erosion of poly(ethylene carbonate) for controlled drug release. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 1232–1237. 20 indexed citations
7.
Chu, Dafeng, Catherine Curdy, Bernd Riebesehl, Moritz Beck‐Broichsitter, & Thomas Kissel. (2013). In situ forming parenteral depot systems based on poly(ethylene carbonate): Effect of polymer molecular weight on model protein release. European Journal of Pharmaceutics and Biopharmaceutics. 85(3). 1245–1249. 13 indexed citations
8.
Librizzi, Damiano, Thomas Endres, Olivia M. Merkel, et al.. (2012). Poly(ethylene carbonate) Nanoparticles as Carrier System for Chemotherapy Showing Prolonged in vivo Circulation and Anti‐Tumor Efficacy. Macromolecular Bioscience. 12(7). 970–978. 7 indexed citations
9.
Kalinowski, Marc, Regina Reul, Sebastian Klaus, et al.. (2011). Drug eluting stents based on Poly(ethylene carbonate): Optimization of the stent coating process. European Journal of Pharmaceutics and Biopharmaceutics. 80(3). 562–570. 33 indexed citations
10.
Reul, Regina, Olivia M. Merkel, Holger Petersen, et al.. (2011). Biodegradable Poly(ethylene carbonate) Nanoparticles as a Promising Drug Delivery System with “Stealth” Potential. Macromolecular Bioscience. 11(7). 897–904. 17 indexed citations
11.
Liu, Yu, et al.. (2010). Poly(ethylene carbonate) as a surface-eroding biomaterial for in situ forming parenteral drug delivery systems: A feasibility study. European Journal of Pharmaceutics and Biopharmaceutics. 76(2). 222–229. 21 indexed citations
12.
Curdy, Catherine, Aarti Naik, Yogeshvar N. Kalia, Ingo Alberti, & Richard H. Guy. (2004). Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo. International Journal of Pharmaceutics. 271(1-2). 251–256. 43 indexed citations
13.
Curdy, Catherine, Yogeshvar N. Kalia, & Richard H. Guy. (2002). Post-iontophoresis recovery of human skin impedance in vivo. European Journal of Pharmaceutics and Biopharmaceutics. 53(1). 15–21. 28 indexed citations
14.
Curdy, Catherine, Yogeshvar N. Kalia, & Richard H. Guy. (2001). Non-invasive assessment of the effects of iontophoresis on human skin in-vivo. Journal of Pharmacy and Pharmacology. 53(6). 769–777. 46 indexed citations
15.
Curdy, Catherine, Yogeshvar N. Kalia, Aarti Naik, & Richard H. Guy. (2001). Piroxicam delivery into human stratum corneum in vivo: iontophoresis versus passive diffusion. Journal of Controlled Release. 76(1-2). 73–79. 43 indexed citations
16.
Curdy, Catherine, Yogeshvar N. Kalia, & Richard H. Guy. (2000). Recovery of human skin impedance in vivo after lontophoresis: Effect of metal ions. Archive ouverte UNIGE (University of Geneva). 2(3). 38–44. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026